Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel
Article in Cancers (August 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
Article in Journal of Cancer Research and Clinical Oncology (July 2023)
Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach
Article in Cancers (September 2022)